Publications by authors named "Brett D Williams"

Claim this Profile
A
An ALK2 inhibitor, BLU-782, prevents heterotopic ossification in a mouse model of fibrodysplasia ossificans progressiva.
Alison J Davis, Natasja Brooijmans, Jason D Brubaker, Faith Stevison, Timothy P LaBranche, Brett D Williams

Sci Transl Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of BLU-945, a Reversible, Potent, and Wild-Type-Sparing Next-Generation EGFR Mutant Inhibitor for Treatment-Resistant Non-Small-Cell Lung Cancer.
Meredith S Eno, Jason D Brubaker, John E Campbell, Chris De Savi, Timothy J Guzi, Brett D Williams

J Med Chem· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enantioselective 1,1-arylborylation of alkenes: merging chiral anion phase transfer with Pd catalysis.
Hosea M Nelson, Brett D Williams, Javier Miró, F Dean Toste

J Am Chem Soc· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mild, diastereoselective construction of cyclic and spirocyclic ketals employing a tandem photoisomerization/cyclization tactic.
Bo Li, Brett D Williams, Amos B Smith

Org Lett· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total synthesis of (+)-18-epi-latrunculol A: development of a synthetic route.
Brett D Williams, Amos B Smith

J Org Chem· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total synthesis of (+)-18-epi-latrunculol A.
Brett D Williams, Amos B Smith

Org Lett· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis